References
- Wake D. Ecstasy overdose: A case study. Intens Crit Care Nurs 1995; 11: 6–9
- Man de R A. Morbidity and mortality as a result of ecstasy consumption. Ned Tijdschr Geneeskd 1994; 138: 1850–1855
- Randall T. Ecstasy-fueled “rave” parties become dances of death for English youths. JAMA 1992; 268: 1505–1506
- Jones A L, Jarvie D R, McDermid G, Proudfoot A T. Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol 1994; 32: 435–444
- Henry J A. Ecstasy and the dance of death. BMJ 1992; 305: 5–6
- Henry J A, Jeffreys K J, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992; 340: 384–387
- Rittoo D B, Rittoo D, Ellis S J, Larner A J. Complications of “ecstasy” misuse. Lancet 1992; 340: 725–726
- Squier M V, Jalloh S, Hilton-Jones D, Series H. Death after ecstasy ingestion: Neuropathological findings. J Neurol Neurosurg Psychiatry 1995; 58: 756–764
- Haddad L M, Shannon W, Winchester J F. Clinical Management of Poisoning and Drug Overdose, 3rd Ed. WB Saunders Company, Philadelphia 1998; 1257
- Rohrig T P, Prouty R W. Tissue distribution of methylenedioxymethamphetamine. J Anal Toxicol 1992; 16: 52–53
- Steele T D, McCann U D, Ricaurte G A. 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”): Pharmacology and toxicology in animals and humans. Addiction 1994; 89: 539–551
- Henderson G L. Designer drugs. Analytical Toxicology for Clinical, Forensic, and Pharmaceutical Chemists., H Brandenberger, R AA Maes. Walter de Gruyter, Berlin-New York 1997; 685–704
- Lim H K, Su Z, Foltz R L. Stereoselective disposition: Enantioselective quantitation of 3,4-(methylene dioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Biol Mass Spec 1993; 22: 403–411
- Dowling G P, Mc Donough E T, Bost R O. “Eve” and “ecstasy”: A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987; 257: 1615–1617
- Barrett P J. “Ecstasy” misuse-overdose or normal dose?. Anaesthesia 1993; 48: 83
- Ames D, Wirshing W C. Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome—a possible link?. JAMA 1993; 269: 869–870
- Milroy C M, Clark J C, Forrest A RW. Pathology of deaths associated with “ecstasy” and “eve” misuse. J Clin Pathol 1996; 49: 149–153
- Miller D B, O'Callaghan J P. Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J Mouse. J Pharmacol Exp Ther 1994; 270: 752–760
- Dafters R I. Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing. Physiology Behavior 1995; 58: 877–882
- Mc Cann U D, Slate S O, Ricaurte G A. Adverse reactions with 3,4-mediylenedioxymethamphetamine (MDMA;“Ecstasy”). Drug Safety 1996; 15: 107–115